Matrix: agarose-based, epoxide-activated
Average particle size: 65 ± 10 µm
Ligand: CaptureSelect CH1-XL affinity ligand
Ligand coupling method: epoxide coupling
Binding capacity: >15 mg/mL human Fab fragment depending on flow rate, column height, contact time. For humanized Fabs lower capacities can be observed.
Elution conditions: 100 mM glycine buffer, pH 3.0; 50 mM acetate buffer, pH 4.0–4.5
Flow rate: 50–200 cm/h (up to 2 bar)
Formulation buffer: 20% (v/v) ethanol
We have developed a unique portfolio of affinity resins that help you develop next-generation antibody therapeutics. These affinity resins can be used for clinical and commercial production and include:
• A platform solution for Fab production parts regardless of light chain type
• Scalable solutions for weak Protein A binding
antibodies and antibody fragments
• Affinity resins offering gentle elution conditions for Fc-fusion proteins and pH-sensitive IgGs
• A cost-effective Protein A resin to help reduce clinical production cost
In addition to affinity resins, we also offer product-specific ELISAs for use in analytical assays to quantify any ligands potentially leached from the column and conjugated ligands.
CaptureSelect helps you develop affinity resins, biosimilars, bio-enhanced products and other types of recombinant proteins.
These affinity resins can be used for clinical and commercial production. CaptureSelect protein purification products, non-antibody biomolecules
Exhibits affinity and specificity for target proteins for efficient one-step purification.